You are here: MEDICA Portal. MEDICA Magazine. Laboratory.
Public Health & Associations
Public Health & Associations
News on public health research and national as well as international health policies. Edited by MEDICA.de and several associations.
Programmable DNA Scissors
( Source: MEDICA.de )
[03/07/2012] Genetic engineers and genomics researchers should welcome the news from the Lawrence Berkeley National Laboratory (Berkeley Lab) where an international team of scientists has discovered a new and possibly more effective means of editing genomes. Programmable DNA Scissors - Read more
Patients on the wrong path
( Source: MEDICA.de )
[02/07/2012] While many physicians immediately think of biomarkers, genetic fingerprinting and new possibilities for cancer treatments when they hear the key words personalized medicine, most patients view the issue differently. They rightly assume that means they receive a treatment that places them in the center – and not just their genes. Patients on the wrong path - Read more
”It can be used for many different applications“
( Source: MEDICA.de )
[22/06/2012] Tracking magnetic particles through the human body – this is one potential application for a new sensor that was developed by Professor Franz Faupel and his team at the Christian Albrecht University of Kiel (CAU) in Germany. In a conversation with the project manager, MEDICA.de found out what makes it different from other sensors and what benefits it can have for medical technology. ”It can be used for many different applications“ - Read more
Rainbow of Light to Image Blood Cells
( Source: MEDICA.de )
[22/05/2012] Blood tests convey vital medical information, but the sight of a needle often causes anxiety and results take time. A new device developed by a team of researchers in Israel, however, can reveal much the same information as a traditional blood test in real-time, simply by shining a light through the skin. Rainbow of Light to Image Blood Cells - Read more
”We are not limited to one active ingredient group or one active ingredient“
( Source: MEDICA.de )
[08/05/2012] Drugs that treat brain diseases such as Alzheimer’s disease or multiple sclerosis are most effective directly where they are needed – in the brain. Unfortunately, it is difficult to develop drugs that are capable of getting there specifically, since the so-called blood-brain barrier prevents this from happening. However, now a team led by Doctor Heiko Manninga succeeded in doing precisely that. ”We are not limited to one active ingredient group or one active ingredient“ - Read more
More informations and functions
MORE ABOUT...
Addiction Adiposity Age Alcohol Allergy Alzheimer's Antibiotics Arthritis Associations Autoimmune Disease Biochip Biocompatible Biofeedback Biomarker Biotechnology Blood Brain Brain Tumour Breast Cancer Cardiovascular Care Career Cells Children Communication COPD Devices Diabetes Diagnostics Drugs Drugs Elderly Persons Emergency Medicine Environment Epilepsy Genetic Material Genetics Germany Global Health Gynecology Headache Health Care Politics Health Insurance Heart Hepatitis HIV Hormones Hospital Hygiene Imaging Immune System Implants Infectious Disease Information Technology Intensive Medicine Interviews Job Market Kidney Knee Laboratory Liver Lung Materials Media MEDICA MEDICA 2008 MEDICA 2010 MEDICA 2011 Medical Errors Medical Markets Microsystems Technology Minimal Invasive MRSA MRT Multiple Sclerosis Nanotechnology Neurology Nutrition Optical Technologies Optimisation Organs Orthopedics Osteoporosis Ovaries Pain Parkinson's Pathogens Patients Photos Physicians Poisoning Polymers Pregnancy Prevention Psychology Quality Rehabilitation Research Rheumatism Risks Safety Screening Screening Senses Sepsis Skin Smoking Stem Cells Stroke Surgery Surgery Tissue Engineering Toxicology Transplantation Treatment Tuberculosis UK USA Vaccination Video Women Wound Healing
